Final results of a phase I study of pegylated liposomal doxorubicin plus gemcitabine in prolonged infusion in patients with recurrent ovarian cancer less than one year

1. Lacave, A. J.
2. Crespo, G.
3. Fonseca, P. J.
4. Villanueva, N.
5. Berros, J. P.
6. Vieitez, J. M.
7. Esteban, E.
8. Losa, R.
9. Sierra, M.